Position in ABBV
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$364,878
+$46,691 QoQ
Shares Held
1,450
-0.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.77%
of 13F equity value
Holder Rank
#3,446
of 4,153 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 20261015 Capital Partners, LLC holds $2,094,651 across 9 Drug Manufacturers - General names. ABBV ranks #4 (17.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
684 | $820,410 | |
| 2 | AMGN |
Amgen Inc
|
1,073 | $388,554 | |
| 3 | JNJ |
Johnson & Johnson
|
1,527 | $387,812 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
1,450 | $364,878 | |
| 5 | MRK |
Merck & Co., Inc.
|
544 | $69,904 | |
| 6 | PFE |
Pfizer Inc
|
1,196 | $28,799 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
418 | $24,085 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
62 | $7,833 |
All Filings in ABBV
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $364,878 | 1,450 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $318,187 | 1,463 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $331,538 | 1,451 | Shares | Sole | 2026-05-11 | |
| No filing history on record for this holder in this stock. | ||||||